Hong Kong-Based Pharma Aptorum Seeks To Raise Up To $30M In US IPO

Login to View

Hong Kong-based pharmaceutical company Aptorum Group Limited is seeking to raise up to US$30 million in an initial public offering of its class A ordinary shares in the U.S., according to a statement released by the company yesterday.

Continue reading with a China Money Network subscription


Join Now

Already have an account or paid subscription? Log in


RELATED NEWS